NeuroSense Therapeutics
NRSN
NRSN
17 hedge funds and large institutions have $964K invested in NeuroSense Therapeutics in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
1.29% more ownership
Funds ownership: 0.84% → 2.13% (+1.3%)
Holders
17
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$216K | |
| 2 | +$72.3K | |
| 3 | +$42.6K | |
| 4 |
Jane Street
New York
|
+$41.6K |
| 5 |
HF
HRT Financial
New York
|
+$31.4K |
Top Sellers
| 1 | -$31K | |
| 2 | -$13.7K | |
| 3 | -$9.95K | |
| 4 |
HC
Hurley Capital
New York
|
-$3.16K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$962 |